Original news and analysis on international IP policy
Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.
Two new civil society observers were admitted last week to the Union for the Protection of New Varieties of Plants (UPOV) though whether that represents a cultural shift for the organisation or simply a procedure that has now been followed depends on who you ask. Meanwhile, a new vice secretary general prepared to take over for the first time in nearly 10 years.
If public procurement for innovation is to be seen as part of developing countries’ industrial-policy portfolio, a recent paper argues accession to the GPA would not help, and advises against it, writes Riaz K. Tayob.
Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.
Europe has promised at the "highest levels" to fix laws that caused generic medicine seizures in the Netherlands, the Indian Minister of Commerce and Industry said today. The minister is in Geneva for meetings on the ongoing Doha Round trade liberalisation talks at the World Trade Organization.
United States Attorney General Eric Holder today called on other governments to join in intensifying the fight against intellectual property infringement, on the theme that, “intellectual property crimes are not victimless.” But his law enforcement argument may need finessing to reach all stakeholders.
The agenda has been circulated for the upcoming annual World Trade Organization review of an amendment to international IP trade law that has so far failed to increase access to needed medicines for the poorest economies. It shows a deeper look at existing measures and opens the possibility of new solutions to the issue.
Now available for Intellectual Property Watch readers: Email alerts for the IP-Watch Burble microblog, our breaking news briefs. A free service available to all, just sign up for email alerts here if you don't already receive them.
If you already receive IP-Watch email alerts, just scroll to the bottom of any email you receive (like this one) and click the link under "If you would like to modify the settings of your subscription," which takes you to your individualised settings. Then add Burble to your categories.
And of course you can also follow us on Twitter or by RSS feed, see www.ip-watch.org.
If you have any questions, please contact us at info@ip-watch.ch.
The countries that own most of the world’s intellectual property rights have all but completed an agreement among themselves that raises the level of protection of those rights while appearing to reduce obligations placed on rights holders. Now they’ll need to find ways to apply it to the countries of the world seen as responsible for much of the infringing material.
More than a dozen ambassadors to the World Trade Organization met today at the New Zealand mission in Geneva to discuss the state of negotiations related to intellectual property rights and trade.
The multilateral system with its different agencies dealing with specific areas is sometimes seen as incoherent in global negotiations and norm-setting as there are overlaps in competency, definition and scope, according to speakers at a side event to the recent World Trade Organization Public Forum.
The World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement has sparked decades of international debate over whether exporting stronger intellectual property norms to developing countries is beneficial or harmful.